BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation
September 22, 2014
September 22, 2014
WASHINGTON, Sept. 22 -- The Biotechnology Industry Organization issued the following news release:
BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO John Castellani in a letter to CMS Administrator Marilyn Tavenner highlighting ongoing concerns about a potential lack of necessary context around the Sunshine data release.
BIO is a member of Partners for Healthy Dialogues, a coalition which has brought indu . . .
BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO John Castellani in a letter to CMS Administrator Marilyn Tavenner highlighting ongoing concerns about a potential lack of necessary context around the Sunshine data release.
BIO is a member of Partners for Healthy Dialogues, a coalition which has brought indu . . .